Delaware | 1-16789 | 04-3565120 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | ||||||||
SIGNATURES |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) | Resignation of a Director | ||
On September 27, 2007, Alfred M. Zeien resigned from the Board of Directors of Inverness Medical Innovations, Inc. (the Company) for health reasons. Mr. Zeiens resignation did not involve any disagreement with the Company on any matter relating to the Companys operations, policies or practices. | |||
Mr. Zeiens resignation creates vacancies on the Boards compensation and nominating committees, as well as the Board itself. The Companys nominating committee will consider candidates to fill these vacancies. |
INVERNESS MEDICAL INNOVATIONS, INC. |
||||
Date: October 1, 2007 | By: | /s/ Jay McNamara | ||
Jay McNamara | ||||
Senior Counsel, Corporate & Finance | ||||